Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

The top 20 highest burdened countries (in disability-adjusted life years) account for more
than 75% of the global burden of viral hepatitis. An effective response in these 20 countries …

Background Direct-acting antivirals opened an opportunity for eliminating hepatitis C virus
(HCV) infection in the Middle East and North Africa (MENA), the region most affected by …

Background and aims People who inject drugs (PWID) are a key population at high risk of
hepatitis C virus (HCV) infection. The aim of this study was to delineate the epidemiology of …

State of the Hepatitis C Virus Care Cascade Page 1 8 | CliniCal liver Disease, vOl 16, nO 1,
JUlY 2020 An Official Learning Resource of AASLD review state of the Hepatitis C virus Care …

This study characterized population-level trends and associations with hepatitis C virus
(HCV) antibody (Ab) prevalence in the Middle East and North Africa (MENA). Data source …

Recent Developments in Applied Microbiology and Biochemistry, Vol. 2, provides a
comprehensive treatment and understanding on application oriented microbial concepts …

To achieve this ambitious goal, 90% of all patients with hepatitis C must be diagnosed in a
timely fashion and about 80% of all eligible patients must be treated with direct-acting …

Background Modelling suggests that achieving the WHO incidence target for hepatitis C
virus (HCV) elimination in Pakistan could cost US 3.87billionover2018to2030.However,theeconomicbenefitsfromintegratingservice …

There are an estimated 2,000 children with β-thalassemia in the province Baluchistan of
Pakistan. These children are at high risk of acquiring transfusion-transmitted infections (TTIs) …